• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TOSOH CORPORATION AIA-900

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TOSOH CORPORATION AIA-900 Back to Search Results
Model Number AIA-900
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/29/2019
Event Type  malfunction  
Manufacturer Narrative
A field service engineering (fse) was at customer's site to resolve reported event.The fse was able to confirm complaint by examining the linearity and qc results but was unable to reproduce the problem.Fse resolved the reported issue by adjusting the incubator and detector temperatures.The analyzer was validated by running fsh calibration, linearity and qc; all results passed without error and within acceptable range.No further action required by field service.The aia-900 analyzer is functioning as expected.A 13-month complaint history review and service history review through aware date of event for similar complaints was performed for serial number (b)(4).There were no similar complaints identified during the search period.The st aia-pack fsh analyte application manual states the following: procedural notes: if a specimen follicle-stimulating hormone concentration is found to be greater than the linearity limit of the assay, 200 miu/ml; the specimen should be diluted with the aia-pack fsh sample diluting solution and re-assayed according to the assay procedure.The recommended dilution for samples containing greater than 200 miu/ml is 1:10 or 1:100.It is desirable to dilute the sample so that the diluted sample reads between 5 and 200 miu/ml.The dilution factor should be entered into the software.For further information on the dilution of specimens, refer to the aia system operator's manual.Evaluation of results quality control in order to monitor and evaluate the precision of the analytical performance, it is recommended that commercially available control samples be assayed daily.The minimum recommendations for the frequency of running internal control material are: after calibration, two levels of controls are run in order to accept the calibration curve.The two levels of controls are also repeated after calibration when certain service procedures are performed (e.G.Temperature adjustment, sampling mechanism changes, maintenance of the wash probe or detector lamp adjustment or change).After daily maintenance, at least two levels of the control should be run in order to verify the overall performance of the tosoh aia system analyzers.If one or more control sample value(s) is out of the acceptable range, it will be necessary to investigate the validity of the calibration curve before reporting patient results.Standard laboratory procedures should be followed in accordance with the regulatory agency under which the laboratory operates.The most probable cause of the reported event was due to incubator & detector temperature adjustment.
 
Event Description
A customer reported getting low linearity and quality control (qc) results for follicle stimulating hormone (fsh) on the aia-900 analyzer.Technical support specialist (tss) reviewed calibration and qc data and noted low qc results.A field service engineer was dispatched to address the reported event, which resulted in delayed reporting of patient samples for fsh.There is no indication of any patient intervention or adverse health consequences due to the delay in reporting of patient results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AIA-900
Type of Device
AIA-900
Manufacturer (Section D)
TOSOH CORPORATION
shiba-koen first building
3-8-2 shiba
minato-ku, 10586 23
JA  1058623
Manufacturer (Section G)
TOSOH CORPORATION
shiba-koen first building
3-8-2 shiba
minato-ku, 10586 23
JA   1058623
Manufacturer Contact
bernadette oconnell
shiba-koen first building
3-8-2 shiba
minato-ku, tokyo 10586-23
JA   1058623
MDR Report Key9386124
MDR Text Key219764019
Report Number8031673-2019-00475
Device Sequence Number1
Product Code KHO
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K971103
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 11/27/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberAIA-900
Device Catalogue Number022930111
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/29/2019
Initial Date FDA Received11/27/2019
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/01/2017
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-